Shows / touchPODCAST
touchPODCAST
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy…
Episodes
- touchPODCAST
What’s new in primary ITP? Key updates from ASH 2024
touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging…
- touchPODCAST
Focused insights: Data implications of ADCs in NSCLC treatment
touchFOCUS for touchRESPIRATORY Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety…
- touchPODCAST
Focused insights: Data implications of ADCs in NSCLC treatment
touchFOCUS for touchONCOLOGY Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety…
- touchPODCAST
Collaboration in chronic ITP: Improving quality of life and patient outcomes - touchSYMPOSIUM for touchONCOLOGY
touchSYMPOSIUM for touchHAEMATOLOGY Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Annual…
- touchPODCAST
Collaboration in chronic ITP: Improving quality of life and patient outcomes - touchSYMPOSIUM for touchHAEMATOLOGY
touchSYMPOSIUM for touchHAEMATOLOGY Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Annual…
- touchPODCAST
Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchONCOLOGY
touchEXPERT FOCUS for touchONCOLOGY Listen to three experts provide insights into the optimal management of neurofibromatosis type 1 (NF1) in paediatric and…
- touchPODCAST
Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchNEUROLOGY
touchEXPERT FOCUS for touchNEUROLOGY Listen to three experts provide insights into the optimal management of neurofibromatosis type 1 (NF1) in paediatric and…
- touchPODCAST
Advancing the treatment of muscle-invasive bladder cancer: Updates on immunotherapy in the perioperative setting
touchEXPERT OPINIONS for touchONCOLOGY Listen to an oncologist, urologist and oncology nurse highlight the key data for immunotherapy in the perioperative…
- touchPODCAST
Navigating treatment choices in high-risk early-stage melanoma - touchDERMATOLOGY
touchEXPERT OPINIONS for touchDERMATOLOGY Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the…
- touchPODCAST
Navigating treatment choices in high-risk early-stage melanoma - touchONCOLOGY
touchEXPERT OPINIONS for touchONCOLOGY Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest…
- touchPODCAST
Advances in IOL technology and power calculations: Updates and innovations from 2024
touchFOCUS for touchOPHTHALMOLOGY Listen to Dr John Ladas, an expert in cataract surgery, as he answers a series of questions on intraocular lens power…
- touchPODCAST
Supporting healing in epidermolysis bullosa: Innovations and new directions for care
touchFOCUS for touchDERMATOLOGY Listen to Prof. Amy Paller as she answers a series of questions on the key features of epidermolysis bullosa, including its…
- touchPODCAST
Primary biliary cholangitis: Appraising the changing therapeutic landscape
touchEXPERT OPINIONS for touchIMMUNOLOGY Listen to a leading expert in hepatology as they explore the current and future management of primary biliary…
- touchPODCAST
Primary biliary cholangitis: Appraising the changing therapeutic landscape
touchEXPERT OPINIONS for touchENDOCRINOLOGY Listen to a leading expert in hepatology as they explore the current and future management of primary biliary…
- touchPODCAST
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4
touchMDT for touchONCOLOGY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team…
- touchPODCAST
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 3
touchMDT for touchONCOLOGY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team…
- touchPODCAST
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4
touchMDT for touchRESPIRATORY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team…
- touchPODCAST
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 3
touchMDT for touchRESPIRATORY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team…
- touchPODCAST
touchMDT for touchRESPIRATORY - What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)?
touchMDT for touchRESPIRATORY What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung…
- touchPODCAST
touchMDT for touchRESPIRATORY - What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)?
touchMDT for touchRESPIRATORY What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)?…
- touchPODCAST
touchMDT for touchRESPIRATORY - What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)?
touchMDT for touchRESPIRATORY What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)? Listen to…
- touchPODCAST
touchMDT for touchONCOLOGY - What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)?
touchMDT for touchONCOLOGY What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer…
- touchPODCAST
touchMDT for touchONCOLOGY - What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)?
touchMDT for touchONCOLOGY What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)?…
- touchPODCAST
touchMDT for touchONCOLOGY - What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)?
touchMDT for touchONCOLOGY What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)? Listen to…
- touchPODCAST
Vaccination strategies for pneumococcal disease
touchEXPERT OPINIONS for touchINFECTIOUS DISEASES In this activity, Prof. Antoni Torres, a leading expert in respiratory infections, discusses the burden of…
- touchPODCAST
Optimizing treatment of CML in the first-line setting and beyond: Insights from EHA 2024 and ESH-iCMLf 2024
touchCONGRESS for touchONCOLOGY Listen to Prof. Gianantonio Rosti, an expert in CML, as he reviews key data presented at the 2024 EHA Hybrid congress and the…
- touchPODCAST
Optimizing treatment of CML in the first-line setting and beyond: Insights from EHA 2024 and ESH-iCMLf 2024
touchCONGRESS for touchHAEMATOLOGY Listen to Prof. Gianantonio Rosti, an expert in CML, as he reviews key data presented at the 2024 EHA Hybrid congress and…
- touchPODCAST
Pharmacological management of agitation in Alzheimer's dementia
touchPANEL DISCUSSION for touchNEUROLOGY Listen to a panel of leading experts discuss best practice in the management of agitation in Alzheimer’s dementia and…
- touchPODCAST
touchIN CONVERSATION - Pulmonary arterial hypertension: A practical roadmap from diagnosis to treatment - touchCARDIO
touchIN CONVERSATION for touchCARDIO Listen to Prof. Manreet Kanwar in conversation with Prof. Jean-Luc Vachiéry, two experts in pulmonary arterial…
- touchPODCAST
touchIN CONVERSATION - Pulmonary arterial hypertension: A practical roadmap from diagnosis to treatment - touchRESPIRATORY
touchIN CONVERSATION for touchRESPIRATORY Listen to Prof. Manreet Kanwar in conversation with Prof. Jean-Luc Vachiéry, two experts in pulmonary arterial…
- touchPODCAST
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 1
touchMDT for touchONCOLOGY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team…
- touchPODCAST
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 2
touchMDT for touchONCOLOGY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team…
- touchPODCAST
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 1
touchMDT for touchRESPIRATORY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team…
- touchPODCAST
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 2
touchMDT for touchRESPIRATORY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team…
- touchPODCAST
Targets in early NSCLC: A focus on EGFR-mutant treatment options
touchFOCUS for touchONCOLOGY Listen to Dr Jennifer Carlisle, an expert in lung cancer, as she answers a series of questions on the targeted perioperative…
- touchPODCAST
Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024
touchCONGRESS for touchONCOLOGY Listen to multiple myeloma expert Prof. María-Victoria Mateos review key data for BCMA-targeting agents in the treatment of…
- touchPODCAST
Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024
touchCONGRESS for touchHAEMATOLOGY Listen to multiple myeloma expert Prof. María-Victoria Mateos review key data for BCMA-targeting agents in the treatment of…
- touchPODCAST
Innovations in glaucoma care: Targeting pathophysiology to expand treatment options
touchEXPERT OPINIONS for touchOPHTHALMOLOGY Listen to leading experts describe the pathophysiology of open-angle glaucoma and discuss how it is targeted by…
- touchPODCAST
Experts in dermatology discuss the latest in treating moderate-to-severe atopic dermatitis in children and adolescents
touchIN CONVERSATION for touchIMMUNOLOGY Listen to Prof. Diamant Thaçi in conversation with Dr Benjamin Ungar. They respond to questions submitted by the HCP…
- touchPODCAST
Experts in dermatology discuss the latest in treating moderate-to-severe atopic dermatitis in children and adolescents
touchIN CONVERSATION for touchDERMATOLOGY Listen to Prof. Diamant Thaçi in conversation with Dr Benjamin Ungar. They respond to questions submitted by the HCP…
- touchPODCAST
Updates in recurrent/metastatic nasopharyngeal carcinoma: The evolving role of immune checkpoint inhibitors
touchFOCUS for touchONCOLOGY Listen to Prof. Barbara Burtness as she answers a series of questions focused on the evolving role of immune checkpoint inhibitors…
- touchPODCAST
touchMDT – A comprehensive approach to symptom care in PBC – Discussion 3 - touchDERMATOLOGY
touchMDT for touchDERMATOLOGY Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain…
- touchPODCAST
touchMDT – A comprehensive approach to symptom care in PBC – Discussion 3 - touchENDOCRINOLOGY
touchMDT for touchENDOCRINOLOGY Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain…
- touchPODCAST
touchMDT – A comprehensive approach to symptom care in PBC – Discussion 3 - touchIMMUNOLOGY
touchMDT for touchIMMUNOLOGY Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE…
- touchPODCAST
touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchDERMATOLOGY
touchMDT for touchDERMATOLOGY Pruritus in PBC and me: The patient experience Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient…
- touchPODCAST
touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchENDOCRINOLOGY
touchMDT for touchENDOCRINOLOGY Pruritus in PBC and me: The patient experience Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient…
- touchPODCAST
touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchIMMUNOLOGY
touchMDT for touchIMMUNOLOGY Pruritus in PBC and me: The patient experience Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient…
- touchPODCAST
touchMDT – Symptom assessment and monitoring in clinical practice – Discussion 2 - touchDERMATOLOGY
touchMDT for touchDERMATOLOGY Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for…
- touchPODCAST
touchMDT – Symptom assessment and monitoring in clinical practice – Discussion 2 - touchENDOCRINOLOGY
touchMDT for touchENDOCRINOLOGY Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for…
- touchPODCAST
touchMDT – Symptom assessment and monitoring in clinical practice – Discussion 2 - touchIMMUNOLOGY
touchMDT for touchIMMUNOLOGY Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for…
- touchPODCAST
Perspectives on EGFR-mutant and wildtype NSCLC: Tailoring treatment advances in late-stage disease - touchRESPIRATORY
touchCLINICAL PERSPECTIVES for touchRESPIRATORY Join Dr Helena Yu, course director, as she discusses the unmet needs and research opportunities in metastatic…
- touchPODCAST
Perspectives on EGFR-mutant and wildtype NSCLC Tailoring treatment advances in late-stage disease - touchONCOLOGY
touchCLINICAL PERSPECTIVES for touchONCOLOGY Join Dr Helena Yu, course director, as she discusses the unmet needs and research opportunities in metastatic…
- touchPODCAST
Expanding HER2 horizons: Implications for NSCLC and beyond
touchPANEL DISCUSSION for touchRESPIRATORY Listen to three experts as they explore tissue-agnostic HER2 targeting in solid tumours, the latest clinical trial…
- touchPODCAST
Expanding HER2 horizons: Implications for NSCLC and beyond
touchPANEL DISCUSSION for touchONCOLOGY Listen to three experts as they explore tissue-agnostic HER2 targeting in solid tumours, the latest clinical trial data…
- touchPODCAST
Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP?
touchCONGRESS for touchHAEMATOLOGY Listen to immune thrombocytopenia (ITP) expert Dr Vickie McDonald review key data presented at the European Hematology…
- touchPODCAST
Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP?
touchCONGRESS for touchONCOLOGY Listen to immune thrombocytopenia (ITP) expert Dr Vickie McDonald review key data presented at the European Hematology…
- touchPODCAST
Continuous glucose monitoring in type 2 diabetes: Overcoming barriers to optimize outcomes
touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to a panel of experts discuss the benefits of CGM in patients with T2D, strategies to overcome the barriers…
- touchPODCAST
Personalizing care within the MDT for patients with early through to advanced RCC
touchFOCUS for touchONCOLOGY Listen to Prof. Hans Hammers as he answers a series of questions on the application of prognostic markers and clinical data within…
- touchPODCAST
Selecting ART: Working with people living with HIV to find the best regimen
touchIN CONVERSATION for touchINFECTIOUS DISEASES Listen to a conversation between Dr Christoph Boesecke and Dr Tristan Barber, two experts on HIV practising…
- touchPODCAST
Thyroid eye disease: An evolving continuum of care
touchPANEL DISCUSSION for touchOPHTHALMOLOGY Listen to a panel of leading experts discuss thyroid eye disease, including the underlying mechanisms, risk…